PETALING JAYA: The National Pharmaceutical Regulatory Agency (NPRA) requires 90 to 120 working days to review documents and make recommendations to the Drug Control Authority (DCA) on the registration of Covid-19 vaccines, says Health director-general Tan Sri Dr Noor Hisham Abdullah.
Dr Noor Hisham said all pharmaceutical products must be registered with the DCA following quality, safety and efficacy evaluations by NPRA before they can be marketed in Malaysia.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
